← back to search

Huiyan Li

Shandong Normal University · CN
Area of research
Molecular Biology · Spectroscopy
Research interest
Research interests include Advanced Biosensing Techniques and Applications, Advanced biosensing and bioanalysis techniques, Extracellular vesicles in disease, and Advanced Proteomics Techniques and Applications.
h-index
32
citations
4,080
works
184
NIH funding
primary concept
email

Recent publications

Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors
Frontiers in Oncology 2025cited by 4position: lastdoi
Effect of body mass index on survival in patients with metastatic colorectal cancer receiving chemotherapy plus bevacizumab: a systematic review and meta-analysis
Frontiers in Nutrition 2024cited by 1position: lastdoi
Polyglycerol‐Amine Covered Nanosheets Target Cell‐Free DNA to Attenuate Acute Kidney Injury
Advanced Science 2023cited by 38position: middledoi
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
Cell Discovery 2021cited by 227position: middledoi
Advances in detection of infectious agents by aptamer-based technologies
Emerging Microbes & Infections 2020cited by 128position: firstdoi
Impact of Electroacupuncture Stimulation on Postoperative Constipation for Patients Undergoing Brain Tumor Surgery
Journal of Neuroscience Nursing 2020cited by 8position: middledoi
The relationship of EZH2 and HOXA5 with non-small cell lung carcinoma patient survival rate
Translational Cancer Research 2020cited by 4position: middledoi
Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS
Cell 2019cited by 578position: middledoi
MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression
Tumor Biology 2016cited by 73position: middledoi
Salt reduction and hypertension in China: a concise state-of-the-art review.
PubMed 2015cited by 22position: middledoi
<i>LAPTM4B</i>gene polymorphism and endometrial carcinoma risk and prognosis
Biomarkers 2013cited by 14position: middledoi
GSTP1, ERCC1 and ERCC2 Polymorphisms, Expression and Clinical Outcome of Oxaliplatin-based Adjuvant Chemotherapy in Colorectal Cancer in Chinese Population
Asian Pacific Journal of Cancer Prevention 2012cited by 31position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Yuqing Li · Anhui Medical University1 papers (2021–2021)Yue Li · Shanghai Medical College of Fudan University1 papers (2020–2020)Jingwen Liu · Hong Kong Polytechnic University1 papers (2021–2021)Qinghua Liu · Beijing Chest Hospital1 papers (2023–2023)Yi Li · State Key Laboratory of Resources and Environmental Information System1 papers (2020–2020)Yi Li · Japan Research Institute1 papers (2023–2023)Li Zhang · Fudan University1 papers (2020–2020)Yi Zhou · Sun Yat-sen University1 papers (2023–2023)Yang Yu · Guangzhou University of Chinese Medicine1 papers (2024–2024)Nan Ma · Indiana University School of Medicine1 papers (2020–2020)Yating Wang · Yangtze University1 papers (2023–2023)Xinhua Yin · Harbin Medical University1 papers (2015–2015)Ge Lou · Harbin Medical University1 papers (2013–2013)Ge Lou · Harbin Medical University1 papers (2016–2016)Hui Mo · Macau University of Science and Technology1 papers (2021–2021)Wen Ni · Sun Yat-sen University1 papers (2021–2021)Luo Chang · South China Agricultural University1 papers (2013–2013)Cai He · Sun Yat-sen University1 papers (2021–2021)Yue Yang · Harbin Medical University1 papers (2020–2020)Xiaohui Lu · Changchun University of Technology1 papers (2023–2023)